Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.
Information source: Astes
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: Chloroprocaine (Drug); Marcaine (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Astes Official(s) and/or principal investigator(s):
Eric P Deflandre, MD, FCCP, Principal Investigator, Affiliation: Astes
Summary
Comparison the use of marcaine and chloroprocaine in rachianesthesia for a surgical
correction of inguinal hernia. Comparision between acute and chronic (3 months and 6 months)
pain.
Clinical Details
Official title: Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Acute pain
Secondary outcome: Chronic pain
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Adults under rachianesthesia
Exclusion Criteria:
- Personal history of gastric ulcus
- ASA 4
- Emergency
- Combined surgery
Locations and Contacts
Clinique Saint-Luc Bouge, Bouge, Namur 5004, Belgium
Additional Information
Starting date: November 2013
Last updated: October 31, 2014
|
